Former Bionano Genomics Chief Medical Officer joins Nabsys at a pivotal moment as the Company expands commercialization of its electronic genome mapping platform Dr. Chaubey will lead medical and scientific affairs strategy as Nabsys works to expand global access to high-resolution structural variant analysis for cancer, constitutional, and cell and gene therapy applications PROVIDENCE, R.I. -- Nabsys [...]

Seer is Delivering Clear Progress Against its Strategic Plan and Maintaining Focus on Cost Discipline, Governance Rigor and Product Innovation  Highly Qualified, Independent and Accountable Board Has Taken Decisive Action to Advance Stockholders’ Best Interests Board Urges Stockholders to Vote “FOR” ONLY Seer’s Director Nominees on the BLUE Proxy Card REDWOOD CITY, Calif. -- Seer, Inc. (Nasdaq: [...]

Board Chair Maria Rankka has today notified the Board of Directors that she will step down as Board Chair and board member of BICO Group AB (publ) effective 31 July 2026. Board members Susanne Lithander and Johan Westman have also informed the Board that they will leave their Board assignments at the same time. The [...]

NEW YORK and FREDERICK, Md. -- Surplus Solutions LLC ("Surplus Solutions"), a portfolio company of NMS Capital ("NMS"), announced today the acquisition of DCM BioServices ("DCM Bio" or the "Company"), a Frederick, Maryland-based provider of laboratory automation maintenance, repair, technical support, and integration solutions. The acquisition expands Surplus Solutions' technical service capabilities and supports the [...]

Software enhancements help researchers simplify complex studies and generate results with confidence Wetzlar, Germany – Leica Microsystems, a Danaher company and a leading provider of microscopy and scientific solutions, announced today the release of Aivia 16, the newest version of its AI-powered image analysis software, helping researchers analyze complex multi-well assay data faster and with [...]

Former Bionano Genomics Chief Medical Officer joins Nabsys at a pivotal moment as the Company expands commercialization of its electronic genome mapping platform Dr. Chaubey will lead medical and scientific affairs strategy as Nabsys works to expand global access to high-resolution structural variant analysis for cancer, constitutional, and cell and gene therapy applications PROVIDENCE, R.I. -- Nabsys [...]

Cambridge, UK – bit.bio, the Cambridge-based human cell programming company, has today announced the launch of two new cell culture media kits designed to make human cell-based research significantly more accessible and affordable for laboratories worldwide. Developed for use with bit.bio's human iPSC-derived ioGlutamatergic Neurons and ioMicroglia, the easy-to-use media kits remove one of the major [...]

LOVELAND, Colo. -- Today, Hach unveils the DR4900 Spectrophotometer to meet laboratories' demand for accurate, efficient, and user-friendly water analysis. Built on Hach's legacy of trusted spectrophotometry technology since 1955, the DR4900 is a next-generation instrument engineered to empower lab professionals in municipal and industrial facilities to achieve precise results. Meet the New DR4900 Spectrophotometer [...]

Agreement expands Active Motif's research genomics portfolio while supporting Arima's strategic focus on its clinical diagnostics platform CARLSBAD, Calif. -- Active Motif, a leading provider of epigenetics and multiomic solutions to mechanistic, translational, and clinical researchers, today announced an exclusive global commercial distribution agreement with Arima Genomics, a cancer diagnostics company built on leadership in [...]

Recently, ACROBiosystems has officially received the "Material Suitability Confirmation for Regenerative Medicine Products" (Certificate No.: 薬機審長発第47号) from the Pharmaceuticals and Medical Devices Agency (PMDA) of Japan for its GMP-grade Human IL-15 protein. This recognition further validates ACROBiosystems' quality system and serves as an authoritative endorsement of its compliance capabilities and expertise in the core raw [...]